Cortex Announces RESOLVE-AF Trial Evaluating Electrographic Flow® (EGF®) Mapping ...

Retrieved on: 2024-02-01 13:46:48

Tags for this article:

Click the tags to see associated articles and topics

Cortex Announces RESOLVE-AF Trial Evaluating Electrographic Flow® (EGF®) Mapping .... View article details on HISWAI: https://menafn.com/1107797608/Cortex-Announces-RESOLVE-AF-Trial-Evaluating-Electrographic-Flow-EGF-Mapping-For-Use-In-Atrial-Fibrillation-Ablation

Summary

The article describes the RESOLVE-AF trial by Cortex for their MedTech product, the Ablamap® System, aimed at personalized ablation strategies for cardiac arrhythmias, focusing on atrial fibrillation using EGF mapping in cardiology.

Article found on: menafn.com

View Original Article